Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page
- Check5 days agoChange DetectedRecruitment status updated to indicate no more participants are being sought. A new Revision: v3.6.0 was added and the previous Revision: v3.5.5 entry was removed.SummaryDifference0.5%

- Check12 days agoChange DetectedThe history entry now shows the latest revision as v3.5.5, replacing the previous v3.5.4. This is a minor version update in the page's history and does not change the study data or visible content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page footer now shows a revision label of v3.5.4, indicating a new release build.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry (v3.5.3) was added to the study record history, replacing the previous revision (v3.5.2). This reflects a platform/version update rather than any change to the trial content.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded a revision entry for v3.5.0 and removed the v3.4.3 entry from the record history.SummaryDifference0.1%

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.